Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Income 1 Regulatory News (MIG1)

Share Price Information for Maven Income 1 (MIG1)

Share Price is delayed by 15 minutes
Get Live Data
33.80    0.00 (0.00%)
Bid:
32.80
Ask:
34.80
Spread: 2.00 (6.098%)
Market Cap: £70.16m
MIG1 Live PriceLast checked at - London Stock Exchange

Intraday Maven Income 1 Share Chart

Directorate Change

29 Nov 2018 10:37

RNS Number : 9093I
Maven Income & Growth VCT PLC
29 November 2018
 

Maven Income and Growth VCT PLC (the Company)

 

Directorate Changes

 

As announced on 26 September 2018, alongside the publication of the Prospectus for the Offer for Subscription, the Board now confirms that Fiona Wollocombe will resign as a Non-executive Director of the Company with effect from 24 January 2019. Mrs Wollocombe has been a Director of the Company since 20 May 2004, serving as its Chairman from 7 July 2005 until 8 July 2010, and the Board wishes to record its gratitude for the significant contribution Fiona made during her time in office and extends to her its best wishes for the future.

 

The Board is also pleased to announce the appointments of Dr Alison Fielding and Dr Andrew Harrington as Non-executive Directors, each with effect from 1 January 2019. Both of these new Directors will also serve on the Company's Audit, Management Engagement, Nomination, Risk and Remuneration Committees, and will stand for election by Shareholders at the Annual General Meeting to be held in July 2019

 

Dr Fielding is an experienced entrepreneur, senior executive and non-executive director, with a track record of leading strategy within both large and small organisations to set direction, evaluate options, implement plans and drive performance. She is currently a venture partner at IP Group plc, with her role there including two non-executive directorships with portfolio companies; Perachem Holdings plc, of which she is chairman, and Getech Group plc, where she chairs the audit committee.

 

Alison has held a number of other non-executive roles and her other current appointments include non-executive directorships of Nanoco Group plc and Queen Mary Innovation Limited, and serving as a trustee of the Royal Voluntary Service and the Carnegie Trust for the Universities of Scotland.

 

Dr Harrington is co-owner of AHV Associates LLP, which was formed in 2001 and works alongside management teams and shareholders across many sectors to advise on transactions, such as the purchase or sale of companies and capital raising.

 

Andrew was previously founder and chief executive of Nextcall Telecom, a business backed by venture and private investor capital, before which he was managing director at Salomon Brothers, where he advised on investment, IPOs, secondary public market offerings and mergers & acquisitions.

 

In relation to both of these new appointments, there is no additional information required to be disclosed pursuant to Listing Rule 9.6.13 R.

 

Maven Capital Partners UK LLP

Secretary

29 November 2018

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAPGGQWGUPRGUB
Date   Source Headline
7th Jun 20126:00 pmRNSFinal Results
6th Jun 20122:16 pmRNSPortfolio Update
18th May 20129:41 amRNSNet Asset Value(s)
23rd Apr 201212:44 pmRNSIssue of Equity
10th Apr 20129:29 amRNSIssue of Equity
2nd Mar 20129:37 amRNSIssue of Equity
20th Jan 20123:31 pmRNSTransaction in Own Shares
19th Jan 20122:25 pmRNSTransaction in Own Shares
16th Jan 20124:23 pmRNSTransaction in Own Shares
13th Jan 20124:04 pmRNSNet Asset Value(s)
7th Dec 20114:22 pmRNSIssue of Equity
30th Nov 20114:51 pmRNSTransaction in Own Shares
29th Nov 20113:54 pmRNSTransaction in Own Shares
28th Nov 20113:09 pmRNSTransaction in Own Shares
7th Nov 20112:30 pmRNSTransaction in Own Shares
4th Nov 201111:06 amRNSTransaction in Own Shares
3rd Nov 20112:39 pmRNSTransaction in Own Shares
2nd Nov 201110:56 amRNSTransaction in Own Shares
1st Nov 201111:18 amRNSTransaction in Own Shares
28th Oct 201112:17 pmRNSTransaction in Own Shares
27th Oct 20113:46 pmRNSTransaction in Own Shares
26th Oct 20113:14 pmRNSTransaction in Own Shares
25th Oct 20113:40 pmRNSTransaction in Own Shares
21st Oct 20114:24 pmRNSHalf Yearly Report
26th Aug 201111:47 amRNSTransaction in Own Shares
20th Jul 20112:44 pmRNSInterim Management Statement
20th Jul 20112:40 pmRNSResult of AGM
17th Jun 20113:58 pmRNSAnnual Information Update
17th Jun 20113:57 pmRNSAnnual Financial Report
4th May 20113:19 pmRNSIssue of Equity
28th Apr 20113:59 pmRNSNet Asset Value(s)
6th Apr 20119:26 amRNSIssue of Equity
2nd Mar 20119:50 amRNSTotal Voting Rights
2nd Feb 20114:05 pmRNSIssue of Equity
27th Jan 20112:50 pmRNSDirector/PDMR Shareholding
17th Jan 20112:18 pmRNSInterim Management Statement
18th Nov 20101:57 pmRNSStatement re Linked Offer for Subscription
4th Nov 20105:13 pmRNSTransaction in Own Shares
22nd Oct 20103:25 pmRNSHalf Yearly Report
22nd Oct 20103:25 pmRNSHalf Yearly Report
19th Aug 20104:42 pmRNSTransaction in Own Shares
13th Jul 201010:36 amRNSInterim Management Statement
8th Jul 20103:12 pmRNSResult of AGM
15th Jun 20108:30 amRNSAnnual Information Update
11th Jun 20102:29 pmRNSAnnual Financial Report
11th May 20108:53 amRNSTotal Voting Rights
11th May 20108:51 amRNSNet Asset Value(s)
4th May 20102:39 pmRNSIssue of Equity
22nd Apr 20103:16 pmRNSStatement re Cancellation of Share Premium Account
6th Apr 201011:11 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.